Formulated for osteoarthritis to alleviate joint inflammation and support physical comfort.
Mechanism of Action
Meloxicam non-selectively inhibits COX-1 and COX-2 enzymes, though it shows relative selectivity for COX-2 at lower doses. This action reduces prostaglandin synthesis, leading to anti-inflammatory and analgesic effects.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
15–20 hours
Contraindications
History of asthma with NSAIDs, Active peptic ulcer, Coronary artery bypass graft surgery, Severe renal impairment
Severe Adverse Events
Gastrointestinal bleeding, Myocardial infarction, Hepatotoxicity — requires immediate medical attention
Information related to Mobic is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
